Authors: Pavlína Suchá; Daniela Kosorínová; Daniela Kapustová; Zuzana Havlíčeková; Miloš Jeseňák Authors‘ workplace: Klinika detí a dorastu, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave a Univerzitná nemocnica Martin, Slovensko Published in: Čes-slov Pediat 2025; 80 (6): 291-294. Category: Case Report doi: https://doi.org/10.55095/CSPediatrie2025/027
Celiac disease is an autoimmune disorder occurring in individuals with a genetic predisposition who consume gluten. The manifestation of celiac disease is diverse, presenting either as a classic gastrointestinal phenotype or througt extraintestinal manifestations. Celiac disease can be associated with liver diseases of various etiologies, including autoimmune liver diseases, celiac hepatitis, metabolic dysfunction-associated steatotic liver disease, or metabolic dysfunction-associated steatohepatitis. Hepatic involvement is usually mild and reversible, although in rare cases, it can progress to liver fibrosis, cirrhosis, and even liver failure. This article presents the case of an 18-year-old patient with hepatopathy of unclear etiology, later diagnosed with metabolic dysfunction-associated steatotic liver disease in the context of ongoing celiac disease. After the patient was placed on a strict gluten-free diet, the hepatic enzymes had normailzed and the hepatophathy had improved. The aim of our article was to highlight a relatively frequent manifestation of celiac disease, emphasize the nessesity for acurate diagnosis and screening in patients with unexplained liver damage, and to point out the fact that in certain cases, adherence to a gluten-free diet may contribute to the improvement of of liver damage.
Celiac disease – hepatopathy – MASLD – liver involvement
1. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease. J pediatr gastroenterol Nutr 2012; 54(1): 136–160.
2. Michalková J, Dimunová L, Mikula P, et al. Vplyv celiakie na kvalitu života adolescentov. Čes-Slov Pediat 2024; 79(2): 98–101.
3. Ambrozová M, Hrunka M, Jabandžiev P. Malabsorpční syndromy. Čes-Slov Pediat 2024; 79(4): 226–232.
4. Rubio-Tapia A, Murray JA. Liver involvement in celiac disease. Minerva Med 2008; 99(6): 595–604.
5. Ghiga G, Boca LO, Cojocaru E, et al. Severe liver damage in an obese patient: onset of celiac disease or overlap syndrome? Diagnostics 2024; 14(16): 1832.
6. Hoffmanová I, Sánchez D, Tučková L, et al. Celiac disease and liver disorders: from putative pathogenesis to clinical implications. Nutrients 2018; 10(7): 892.
7. Casella G, Viganò D, Romano Settanni C, et al. Association between celiac disease and chronic hepatitis C. Gastroenterol Hepatol Bed Bench 2016; 9(3): 153–157.
8. Wiest R, Albillos A, Trauner M, et al. Targeting the gut-liver axis in liver disease. J Hepatol 2017; 67(5): 1084–1103.
9. Schneider KM, Albers S, Trautwein C. Role of bile acids in the gut-liver axis. J Hepatol 2018; 68(5): 1083–1085.
10. Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016; 4(4): e1251384.
11. De Re V, Magris R, Cannizzaro R. New Insights into the Pathogenesis of Celiac Disease. Front Med (Lausanne) 2017; 4 : 137.
12. Araújo AR, Rosso N, Bedogni G, et al. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future. Liver Int 2018; 38(1): 47–51.
13. Scapaticci S, Venanzi A, Chiarelli F, et al. MAFLD and Celiac Disease in Children. IJMS 2023; 24(2): 1764.
14. Reilly NR, Lebwohl B, Hultcrantz R, et al. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol 2015; 62(6): 1405–1411.
15. Lee GJ, Boyle B, Ediger T, et al. Hypertransaminasemia in newly diagnosed pediatric patients with celiac disease. J Pediatr Gastroenterol Nutr 2016; 63(3): 340–343.
16. Villavicencio Kim J, Wu GY. Celiac disease and elevated liver enzymes: a review. J Clin Translat Hepatol 2021; 9(1): 116–124.
17. Rubio-Tapia A, Murray JA. The liver and celiac disease. Clin Liver Dis 2019; 23(2): 167–176.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
